We identified 15q13.3 microdeletions encompassing the CHRNA7 gene in 12 of 1,223 individuals with idiopathic generalized epilepsy (IGE), which were not detected in 3,699 controls (joint P = 5.32 × 10−8). Most deletion carriers showed common IGE syndromes without other features previously associated with 15q13.3 microdeletions, such as intellectual disability, autism or schizophrenia. Our results indicate that 15q13.3 microdeletions constitute the most prevalent risk factor for common epilepsies identified to date.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Jallon, P. & Latour, P. Epilepsia 46 (Suppl. 9), 10–14 (2005).
Ottman, R. Epilepsia 46 (Suppl. 10), 7–14 (2005).
Sharp, A.J. et al. Nat. Genet. 40, 322–328 (2008).
International Schizophrenia Consortium. Nature 455, 237–241 (2008).
Stefansson, H. et al. Nature 455, 232–236 (2008).
Miller, D.T. et al. J. Med. Genet. advance online publication, doi:10.1136/jmg.2008.059907 (19 September 2008).
Neubauer, B.A. et al. Neurology 51, 1608–1612 (1998).
Elmslie, F.V. et al. Hum. Mol. Genet. 6, 1329–1334 (1997).
Sander, T. et al. Hum. Mol. Genet. 9, 1465–1472 (2000).
Helbig, I., Scheffer, I.E., Mulley, J.C. & Berkovic, S.F. Lancet Neurol. 7, 231–245 (2008).
Steinlein, O.K. & Bertrand, D. Biochem. Pharmacol. 76, 1175–1183 (2008).
Breese, C.R. et al. J. Comp. Neurol. 387, 385–398 (1997).
Blumenfeld, H. Epilepsia 46 (Suppl. 9), 21–33 (2005).
We thank all the subjects and their families for participating in this study. We are also grateful to H. Bode for referral of subjects and A. Ackerhans and K. Moldenhauer for database management. This study used samples from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), as well as clinical data. NINDS Repository sample numbers corresponding to the samples used are available upon request. This study was supported by grants from the German Research Foundation (SA434/4-1, T.S., P.N.), the German Federal Ministry of Education and Research (National Genome Research Network, NGFN-2: NeuroNet, NGFNplus: EMINet), the European Community (FP6 Integrated Project EPICURE, LSHM-CT-2006-037315; grant agreement 219250, A.J.S.), the PopGen biobank, the University of Kiel (I.H.), the Danish National Research Foundation (R.S.M.), in part by grants from the NIH (HD043569, E.E.E.), the National Epilepsy Funds (NEF, grant no. 04-08, B.P.C.K., D. Lindhout), the Netherlands Organization for Scientific Research (NOW, grant no. 917.66.315, B.P.C.K., C.d.K.) and the German Research Foundation/German Federal Ministry of Education and Research (DFG/BMBF) excellence cluster “Inflammation at Interfaces” (A.F., M.W., S.S.). E.E.E. is an investigator of the Howard Hughes Medical Institute.
About this article
Cite this article
Helbig, I., Mefford, H., Sharp, A. et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41, 160–162 (2009). https://doi.org/10.1038/ng.292
Acta Clinica Belgica (2021)
Clinical Neurology and Neurosurgery (2021)
Journal of Neurochemistry (2020)
Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder
Genes, Brain and Behavior (2020)
De novo duplication on Chromosome 19 observed in nuclear family displaying neurodevelopmental disorders
Molecular Case Studies (2020)